trial · primary record
ES104
Metastatic Colorectal Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2023-03-24 |
| Primary endpoint | Phase 1: The frequency and severity of adverse events of ES104 |
| Registry ID | NCT05167448 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:57.878Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05167448
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.